DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 Genetic Test
Welcome to DNA Labs UAE, where we offer the DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 Genetic Test. This test is designed to diagnose and manage individuals suspected of having ARVC type 8, a genetic disorder that affects the heart muscle.
Test Components and Price
- Components: NGS Technology
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
Test Type and Doctor
The DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is recommended to consult a Cardiologist for this test.
Test Department and Pre Test Information
The test is conducted in our Genetics department. Before undergoing the DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 NGS Genetic DNA Test, it is essential to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by ARVC type 8.
Understanding ARVC
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder that primarily affects the right ventricle of the heart. This condition is characterized by the replacement of normal heart muscle with fatty or fibrous tissue, leading to abnormal heart rhythms and potentially life-threatening arrhythmias.
About NGS Genetic Testing
Next-Generation Sequencing (NGS) genetic testing is a diagnostic tool used to identify genetic mutations associated with various diseases, including ARVC. It involves sequencing the DNA of an individual to identify specific genetic variants or mutations that may be causing the condition.
The Role of the DSP Gene
The DSP (Desmoplakin) gene has been associated with ARVC, particularly ARVC type 8. Mutations in the DSP gene can disrupt the normal function of desmoplakin, a protein responsible for maintaining the structural integrity of heart muscle cells. This disruption can lead to the development of ARVC type 8.
About the DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 NGS Genetic Test
The DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 NGS Genetic Test utilizes NGS technology to analyze the DSP gene for mutations or variants that may be associated with ARVC type 8. This test aids in the diagnosis and management of individuals suspected of having ARVC.
For more information or to schedule a test, please contact our Genetic department.
Test Name | DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 NGS Genetic DNA Test gene DSP |
Test Details |
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder that affects the heart muscle, particularly the right ventricle. It is characterized by the replacement of normal heart muscle with fatty or fibrous tissue, leading to abnormal heart rhythms and potentially life-threatening arrhythmias. NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool used to identify genetic mutations associated with various diseases, including ARVC. It involves sequencing the DNA of an individual to identify any specific genetic variants or mutations that may be causing the condition. DSP (Desmoplakin) is a gene that has been associated with ARVC, specifically ARVC type 8. Mutations in the DSP gene can disrupt the normal function of desmoplakin, a protein involved in maintaining the structural integrity of heart muscle cells. This disruption can lead to the development of ARVC. Therefore, the “DSP Gene Arrhythmogenic right ventricular cardiomyopathy type 8 NGS Genetic Test” refers to a genetic test that uses NGS technology to analyze the DSP gene for mutations or variants that may be associated with ARVC type 8. This test can help in the diagnosis and management of individuals suspected of having ARVC. |